Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Looking for quick cash without a job? Discover various ways to receive cash today without work and boost your finances effortlessly.
25,802 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Warren Buffett's looming Berkshire Hathaway exit plans could reshape both philanthropy and investing. This analysis e...
Hims & Hers announces a billion-dollar cross-border deal to expand telehealth and wellness services, signaling a bold...
Real Brokerage reports 2025 revenue approaching $2 billion, signaling the strength of a platform-first approach that ...
A high-profile Arkansas event sparked financial ripples as sponsors and donors paused amid controversy. This article ...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
Canadian traders face a fast-moving market in May 2026 as platforms race to lower costs and boost real-time data. Thi...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
As AI accelerates,Microsoft's split with OPENAI could reshape strategy and investor returns. Learn what this means fo...
With unemployment data signaling a slower hiring cycle, investors are turning to enterprise automation. This article ...
A zero-premium Medicare Advantage plan can look flawless until a serious illness triggers large bills. The case highl...
Analysts convene Thursday to highlight key stock moves ahead of a holiday weekend, with fresh targets and cautions ac...